{"log_id": 6238798713191498787, "direction": 0, "words_result_num": 52, "words_result": [{"probability": {"variance": 0.030847, "average": 0.900665, "min": 0.471168}, "location": {"width": 1129, "top": 187, "height": 38, "left": 276}, "words": "泮托拉为质子泵抑制剂,通过与导壁细胞的U-KATP酶系统的两个位点共介结合而如制"}, {"probability": {"variance": 0.040902, "average": 0.877149, "min": 0.358276}, "location": {"width": 1182, "top": 226, "height": 36, "left": 224}, "words": "胃酸产生的最后步骤,该作用剂益依赖性并生基研末刺激状态下的胃酸分泌划受排制。本品"}, {"probability": {"variance": 0.010347, "average": 0.95681, "min": 0.582249}, "location": {"width": 797, "top": 262, "height": 36, "left": 224}, "words": "与H-KATP的的结合可导致其抗胃酸分泌作用持续24小时以上"}, {"probability": {"variance": 0.019305, "average": 0.870347, "min": 0.652938}, "location": {"width": 118, "top": 304, "height": 32, "left": 219}, "words": "毒理研究"}, {"probability": {"variance": 0.015651, "average": 0.88446, "min": 0.710562}, "location": {"width": 118, "top": 340, "height": 34, "left": 219}, "words": "遗传性"}, {"probability": {"variance": 0.008696, "average": 0.956761, "min": 0.57716}, "location": {"width": 1127, "top": 377, "height": 43, "left": 276}, "words": "泮托拉唑的人淋已细胞染色体畸变试验、中玉仓鼠卵巢胞HGP3T正向突变试验及二次小"}, {"probability": {"variance": 0.015891, "average": 0.942344, "min": 0.50342}, "location": {"width": 1186, "top": 418, "height": 36, "left": 219}, "words": "鼠微核试验中的次结果均为阳性,而大鼠肝脏DNA共价结合试验纪果难以判断T,Ames试"}, {"probability": {"variance": 0.013083, "average": 0.931409, "min": 0.542345}, "location": {"width": 1186, "top": 454, "height": 36, "left": 217}, "words": "验、大鼠细胞程序外NA合成试验(LDS)、AS52GPT哺乳动物细上向基因突变试验,小"}, {"probability": {"variance": 0.022021, "average": 0.92948, "min": 0.353364}, "location": {"width": 1188, "top": 493, "height": 38, "left": 217}, "words": "鼠淋已瘤L5178Y细胞赢嘧啶酶突变试验及体内大鼠骨髓细胞染色体畸变试验结果均为阴"}, {"probability": {"variance": 0, "average": 0.999485, "min": 0.999485}, "location": {"width": 36, "top": 532, "height": 32, "left": 217}, "words": "性"}, {"probability": {"variance": 0.00739, "average": 0.94791, "min": 0.79905}, "location": {"width": 121, "top": 567, "height": 36, "left": 214}, "words": "生殖毒性"}, {"probability": {"variance": 0.012835, "average": 0.940044, "min": 0.483673}, "location": {"width": 1131, "top": 605, "height": 41, "left": 274}, "words": "雄性大鼠经口给予浮托拉唑500 mg,'kg'd(按体表面积折算,为临床推荐口服剂98"}, {"probability": {"variance": 0.006926, "average": 0.968551, "min": 0.464897}, "location": {"width": 1186, "top": 644, "height": 45, "left": 217}, "words": "倍),雌性大鼠经口给予泮托拉唑450mgKg/(按体表面积折算,为床推荐口服剂量的88"}, {"probability": {"variance": 0.002884, "average": 0.978748, "min": 0.765427}, "location": {"width": 516, "top": 685, "height": 34, "left": 219}, "words": "倍)时,生育力及生殖行为未见明显异常"}, {"probability": {"variance": 0.028258, "average": 0.891282, "min": 0.476444}, "location": {"width": 1134, "top": 724, "height": 41, "left": 272}, "words": "大鼠静泳给予折拉唑20 mg: Kgd按体表面积折算,为临床推荐口服剂量的4倍),家兔"}, {"probability": {"variance": 0.033099, "average": 0.872919, "min": 0.400887}, "location": {"width": 1188, "top": 761, "height": 41, "left": 214}, "words": "静脉给予泮托拉唑15mgKd(按体表面算,为临未荐二量的6倍),对生育力和胎"}, {"probability": {"variance": 0.006226, "average": 0.964599, "min": 0.677731}, "location": {"width": 804, "top": 797, "height": 43, "left": 214}, "words": "仔均未见明显损害,泮托拉唑及其代谢产物可从家兔乳汁中分泌"}, {"probability": {"variance": 0.00025, "average": 0.987647, "min": 0.965278}, "location": {"width": 89, "top": 841, "height": 29, "left": 219}, "words": "致癌性"}, {"probability": {"variance": 0.032428, "average": 0.873224, "min": 0.419369}, "location": {"width": 1122, "top": 877, "height": 41, "left": 283}, "words": "D大连续24个月经口给予洋托拉唑0.5~200g/Kkg,胃底出现量依赖性的肠哮铭样"}, {"probability": {"variance": 0.037584, "average": 0.858096, "min": 0.406299}, "location": {"width": 1188, "top": 912, "height": 50, "left": 217}, "words": "细抱增生及良性和恶性的神经内分泌细胞瘤。当剂至为50和200 mgid(按公表面积算,海"}, {"probability": {"variance": 0.020198, "average": 0.922048, "min": 0.39171}, "location": {"width": 1223, "top": 955, "height": 48, "left": 217}, "words": "临床推荐口剂量的1040倍)时,前写出现良性鳞状细跑乳头状瘤和恶性鳞细胞癌拌"}, {"probability": {"variance": 0.023026, "average": 0.912551, "min": 0.494835}, "location": {"width": 1191, "top": 994, "height": 43, "left": 214}, "words": "托拉唑还导致极少数大鼠山现胃道胆瘤,包括50mgKg剂时偶尔出现十二指肠癌;以"}, {"probability": {"variance": 0.013394, "average": 0.923506, "min": 0.508822}, "location": {"width": 1195, "top": 1028, "height": 54, "left": 214}, "words": "200 mg/Kg/d剂量时胃底出现良性忘肉和痛。泮托拉唑给药剂全0.5~20mg/Kgd时人鼠"}, {"probability": {"variance": 0.023431, "average": 0.891292, "min": 0.429858}, "location": {"width": 1218, "top": 1067, "height": 50, "left": 212}, "words": "剂三依赖生地出现肝细胞腺痹和开,200mgK2d剂量还可使大鼠状腺粪沧细胞和曩泡细"}, {"probability": {"variance": 0.034409, "average": 0.879209, "min": 0.440412}, "location": {"width": 1047, "top": 1108, "height": 41, "left": 214}, "words": "胞的发生增加:SD大鼠6个月和12个月的毒怡研究中也偶见开细胞棕瘤和开溶"}, {"probability": {"variance": 0.017276, "average": 0.924753, "min": 0.412564}, "location": {"width": 1131, "top": 1145, "height": 45, "left": 272}, "words": " Fischer344大鼠连续24个月经口给予泮托拉唑550 my, KE d(按体表面积折算为床排"}, {"probability": {"variance": 0.018152, "average": 0.941532, "min": 0.392521}, "location": {"width": 1186, "top": 1184, "height": 41, "left": 214}, "words": "荐二服剂量的1~10倍),胃底剂量依赖性出现肠嗜铬样细胞增生及良性和恶的神经内分泌细"}, {"probability": {"variance": 0.026211, "average": 0.923086, "min": 0.37294}, "location": {"width": 914, "top": 1223, "height": 38, "left": 212}, "words": "围瘤。但该试验的剂量选择不足以支持对泮托唑潜在致癌性的充分评价"}, {"probability": {"variance": 0.019981, "average": 0.918866, "min": 0.352406}, "location": {"width": 1129, "top": 1257, "height": 50, "left": 272}, "words": "B6C3F1小鼠连续24个月经口服给子浮托拉唑5~150 img'kgfd(按体表面积算,为临床推"}, {"probability": {"variance": 0.033114, "average": 0.881097, "min": 0.367103}, "location": {"width": 1182, "top": 1298, "height": 48, "left": 217}, "words": "荐1服剂量的0.5-15倍)同样出现胃底肠铬栏细胞增生:雌鼠在150mg小剂时,肝"}, {"probability": {"variance": 0.01178, "average": 0.925499, "min": 0.640352}, "location": {"width": 377, "top": 1337, "height": 36, "left": 212}, "words": "细胞腺瘤和肝癌的发生率升高"}, {"probability": {"variance": 0.021865, "average": 0.916356, "min": 0.487167}, "location": {"width": 1108, "top": 1376, "height": 43, "left": 272}, "words": "上述齿关动物的致痛件研究结果提示本品具有一定的致癌性,但结果与临床的关"}, {"probability": {"variance": 0.069096, "average": 0.847853, "min": 0.392566}, "location": {"width": 118, "top": 1415, "height": 32, "left": 214}, "words": "尚不楚"}, {"probability": {"variance": 5.2e-05, "average": 0.99251, "min": 0.979102}, "location": {"width": 173, "top": 1451, "height": 34, "left": 224}, "words": "【药代动力学】"}, {"probability": {"variance": 0.03004, "average": 0.903501, "min": 0.425996}, "location": {"width": 1102, "top": 1486, "height": 43, "left": 269}, "words": "绊托拉唑血药峰浓度(Cmxy和血药浓度时间由线下面积CAUC与10g80m静脉"}, {"probability": {"variance": 0.019983, "average": 0.938207, "min": 0.427428}, "location": {"width": 1166, "top": 1527, "height": 45, "left": 210}, "words": "注射给药剂量增加成比例,泮拉唑不菩积每日多次给药不改变其代动力学性:脉"}, {"probability": {"variance": 0.020679, "average": 0.930782, "min": 0.395193}, "location": {"width": 1161, "top": 1566, "height": 41, "left": 212}, "words": "注射泮托拉唑钠后,其血药浓度快速下,消除半衰期约为一小时,在p2C1生区代谢"}, {"probability": {"variance": 0.028664, "average": 0.899284, "min": 0.425116}, "location": {"width": 1161, "top": 1607, "height": 43, "left": 212}, "words": "型且肝功能正常的人群中,十工分钟内但静就注射洋托拉理钠40mg的剂全程浓度"}, {"probability": {"variance": 0.046903, "average": 0.839871, "min": 0.204713}, "location": {"width": 1102, "top": 1643, "height": 50, "left": 324}, "words": "为5212ml,血药浓度间的总曲线下面积为5.41.5 ue/,总清除率为"}, {"probability": {"variance": 0.011882, "average": 0.906085, "min": 0.637944}, "location": {"width": 160, "top": 1685, "height": 29, "left": 212}, "words": "7.6~14.0L/h"}, {"probability": {"variance": 0, "average": 0.999831, "min": 0.999802}, "location": {"width": 64, "top": 1721, "height": 29, "left": 210}, "words": "分布"}, {"probability": {"variance": 0.024586, "average": 0.906146, "min": 0.43281}, "location": {"width": 1102, "top": 1755, "height": 38, "left": 267}, "words": "汗托拉唑的表观分布容积约为11.~23.6L,主要分布在细胞外液。泮托拉的直洁蛋白"}, {"probability": {"variance": 0, "average": 0.91944, "min": 0.91944}, "location": {"width": 52, "top": 1744, "height": 43, "left": 1406}, "words": "江"}, {"probability": {"variance": 0.000117, "average": 0.992159, "min": 0.956442}, "location": {"width": 381, "top": 1790, "height": 38, "left": 212}, "words": "结合率约98%,主要为白蛋白"}, {"probability": {"variance": 0.00082, "average": 0.971337, "min": 0.942699}, "location": {"width": 59, "top": 1831, "height": 32, "left": 212}, "words": "代谢"}, {"probability": {"variance": 0.010174, "average": 0.94837, "min": 0.558123}, "location": {"width": 1106, "top": 1865, "height": 48, "left": 267}, "words": "泮托拉唑广泛在肝脏通过细胞色素P450CYP)系统代谢:药物代谢与药途径(泳"}, {"probability": {"variance": 0.009628, "average": 0.95642, "min": 0.528331}, "location": {"width": 1163, "top": 1906, "height": 41, "left": 210}, "words": "药或口服)无关,主要代谢途径是由CYP2C19基因去甲基化后硫酸化,其他代谢途径包括"}, {"probability": {"variance": 0.011138, "average": 0.949027, "min": 0.456357}, "location": {"width": 1161, "top": 1947, "height": 36, "left": 210}, "words": "通过CYP3A4氧化,没有证据表明托拉唑代谢物有显著的药理活性。CYP2C19因一些亚"}, {"probability": {"variance": 0.024687, "average": 0.920876, "min": 0.369576}, "location": {"width": 1159, "top": 1984, "height": 36, "left": 210}, "words": "群的缺失而具遗传多态(例如,3%的白人和非美国人以及17%~23%的亚洲人》,虽"}, {"probability": {"variance": 0.015551, "average": 0.920848, "min": 0.514459}, "location": {"width": 1159, "top": 2018, "height": 43, "left": 210}, "words": "然亚群缓慢代谢泮托拉的消除半衰期值为3.5到10.小时,但他们每元给药一次,善积很"}, {"probability": {"variance": 0.015438, "average": 0.927984, "min": 0.656062}, "location": {"width": 148, "top": 2057, "height": 29, "left": 212}, "words": "少(<235"}, {"probability": {"variance": 0.00066, "average": 0.974166, "min": 0.948471}, "location": {"width": 59, "top": 2094, "height": 32, "left": 212}, "words": "排泄"}], "language": 3}